Published on
November 13, 2024
- 14:00 GMT
Helix Biopharma Corp. Enters into Non-Binding Letter of Intent to Acquire Laevoroc Group’s Oncology Assets
The Companies Aim to Close Definitive Agreements Before Year-End Helix Biopharma Corp. (TSX:HBP) TORONTO, ONTARIO, CANADA, November 13, 2024 /EINPresswire.com/ -- Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the …
Distribution channels:
Banking, Finance & Investment Industry, Companies
...
